A Troublesome Subject – Exploring the possible connection between intelligence and Parkinson’s and Alzheimer's diseases

[1]  Rex E. Jung,et al.  Diffusion markers of dendritic density and arborization in gray matter predict differences in intelligence , 2018, Nature Communications.

[2]  I. Deary,et al.  Childhood Cognitive Ability and Incident Dementia: The 1932 Scottish Mental Survey Cohort into their 10th Decade , 2017, Epidemiology.

[3]  Giora Volpert,et al.  Altered lysosome distribution is an early neuropathological event in neurological forms of Gaucher disease , 2017, FEBS letters.

[4]  M. Albert,et al.  Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. , 2016, JAMA neurology.

[5]  W. Gahl,et al.  Lysosomal storage diseases , 2016, Translational science of rare diseases.

[6]  Itsik Pe'er,et al.  The time and place of European admixture in Ashkenazi Jewish history , 2016, bioRxiv.

[7]  N. Pedersen,et al.  Socioeconomic status in relation to Parkinson's disease risk and mortality , 2016, Medicine.

[8]  G. Lopez,et al.  Clinical course and prognosis in patients with Gaucher disease and parkinsonism , 2016, Neurology: Genetics.

[9]  R Plomin,et al.  Genetics and intelligence differences: five special findings , 2014, Molecular Psychiatry.

[10]  Kenneth Offit,et al.  Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins , 2014, Nature Communications.

[11]  J. Edwards,et al.  Occupational Complexity and Risk of Parkinson's Disease , 2014, PloS one.

[12]  M. Stephens,et al.  An Estimate of the Average Number of Recessive Lethal Mutations Carried by Humans , 2014, Genetics.

[13]  I. Pe’er,et al.  Length distributions of identity by descent reveal fine-scale demographic history. , 2012, American journal of human genetics.

[14]  E. Sidransky,et al.  The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders , 2010, Current neurology and neuroscience reports.

[15]  A. Singleton,et al.  Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. , 2009, Brain : a journal of neurology.

[16]  D. Grosset,et al.  Geographical difference in Parkinson's disease prevalence within West Scotland , 2009, Movement disorders : official journal of the Movement Disorder Society.

[17]  Kevin R. Sanft,et al.  Education and occupations preceding Parkinson disease , 2005, Neurology.

[18]  David A. Snowdon,et al.  Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study , 2005, Neurobiology of Aging.

[19]  Anthony H. Futerman,et al.  The cell biology of lysosomal storage disorders , 2004, Nature Reviews Molecular Cell Biology.

[20]  M. Hammer,et al.  MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population , 2004, European Journal of Human Genetics.

[21]  David A. Snowdon,et al.  Healthy Aging and Dementia: Findings from the Nun Study , 2003, Annals of Internal Medicine.

[22]  S. Walkley.  Neurobiology and cellular pathogenesis of glycolipid storage diseases. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[23]  N. Risch,et al.  Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection. , 2003, American journal of human genetics.

[24]  F. Boas,et al.  Linkage to Gaucher mutations in the Ashkenazi population: effect of drift on decay of linkage disequilibrium and evidence for heterozygote selection. , 2000, Blood cells, molecules & diseases.

[25]  N. Risch,et al.  Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations. , 2000, American journal of human genetics.

[26]  J. Holden,et al.  Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys , 1998, The Journal of comparative neurology.

[27]  M. Natowicz,et al.  Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain. , 1996, Journal of medical genetics.

[28]  K. Hirschberg,et al.  A Regulatory Role for Sphingolipids in Neuronal Growth , 1995, The Journal of Biological Chemistry.

[29]  G. Giovino,et al.  Trends in cigarette smoking among US physicians and nurses. , 1994, JAMA.

[30]  P. Moens,et al.  Heterozygote advantage in Tay-Sachs carriers? , 1981, American journal of human genetics.

[31]  R. Lynn.  The intelligence of American Jews , 2004 .

[32]  M. Riklan,et al.  Psychological studies in dystonia musculorum deformans. , 1976, Advances in neurology.

[33]  N. Myrianthopoulos,et al.  Population Dynamics of Tay-Sachs Disease. II. What Confers the Selective Advantage Upon the Jewish Heterozygote? , 1972 .